Searchable abstracts of presentations at key conferences in endocrinology

ea0020p85 | Thyroid | ECE2009

Is there any beneficial effect of L-thyroxine replacement theraphy on cardiovascular risk factors in patients with subclinical hypothyroidism?

Unal Oguz Kaan , Erturk Erdinc , Sarandol Emre , Eroz Esma , Kiyici Sinem , Guclu Metin , Imamoglu Sazi

The relationship between increased risk of cardiovascular disease (CVD) and atherosclerosis in subclinical hypothyroidism (sHT) have been demonstrated in several studies. This relation was attributed to dyslipidemia which is common in sHT. Apo A1, apo B100, Lp (a), hsC-reactive protein (hsCRP), fibrinogen and total homocysteinemia (tHcy) are the main non-traditional cardiovascular risk factors. In addition, paraoxon 1 (PON 1) activity is an enzyme responsible for the anti-oxid...